SEC Form 4 · accession 0001289340-15-000051
Stereotaxis, Inc. · STXS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred A Middleton
Director
Period of report
Jun 2, 2015
Accepted (ET)
Jun 3, 2015 · 11:46 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001289340
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2015 | A | 10,000 | $0.00 | A | 46,810 | D | |
| Common Stock | holding | — | — | — | 1,256,402 | I | Sanderling Venture Partners VI Co-Investment Fund, L.P. | |
| Common Stock | holding | — | — | — | 40,673 | I | Sanderling Ventures Management VI | |
| Common Stock | holding | — | — | — | 6,358 | I | Sanderling VI Limited Partnership | |
| Common Stock | holding | — | — | — | 5,335 | I | Sanderling VI Beteiligungs GmbH & Co. KG | |
| Common Stock | holding | — | — | — | 1,500 | I | Sanderling Mgmt. LLC 401K Pension Profit Sharing Plan | |
| Common Stock | holding | — | — | — | 53,275 | I | Sanderling IV Biomedical Co-Investment Fund, L.P. | |
| Common Stock | holding | — | — | — | 11,097 | I | Sanderling V Beteiligungs GmbH & Co. KG | |
| Common Stock | holding | — | — | — | 39,716 | I | Sanderling V Biomedical Co-Investment Fund, L.P. | |
| Common Stock | holding | — | — | — | 11,956 | I | Sanderling V Limited Partnership | |
| Common Stock | holding | — | — | — | 67,790 | I | Sanderling Venture Partners V Co-Investment Fund, L.P. | |
| Common Stock | holding | — | — | — | 22,451 | I | Sanderling Venture Partners IV Co-Investment Fund | |
| Common Stock | holding | — | — | — | 82 | I | Sanderling Ventures Management V |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest one year from the date of the grant or the date of the next annual shareholders meeting, whichever is earlier.